The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis released evidence-based treatment recommendations for the diagnosis and management of comorbidities associated with psoriatic arthritis.
The guidelines are the result of a collaborative effort by rheumatologists, dermatologists, and patient representatives from Europe and North America known as the Psoriatic Arthritis Forum and were published in the journal Arthritis Care and Research.
The first of these recommendations, which will be reviewed again prior to formal adoption, is that all patients with psoriatic arthritis should be evaluated for cardiovascular disease. The consensus group labeled this recommendation “strong,” although it was based on grade D evidence.
Additional recommendations included:
- Development of a screening tool for patients with psoriatic arthritis
- Increased awareness of all issues related to psoriatic arthritis, including disease progression and health-related quality of life components
- Improved communication between health care providers and patients
In addition to better screening, experts called for improved referrals for patients with psoriatic arthritis comorbidities, as well as a step-by-step procedure for improving patient evaluation and treatment.